FDA Approves First At-Home Test for Cervical Cancer Screenings

The FDA recently approved Teal Health’s at-home cervical cancer test, marking a significant step in making screenings more accessible. Unlike traditional pap smears, which require a speculum insertion, Teal Health’s device uses a spongelike wand for a less invasive, more comfortable process. This innovation aims to empower women with a simpler option that could help bridge the gap in cervical cancer screening rates, particularly in rural areas and among those without insurance coverage. Studies show at-home tests can significantly increase screening rates when distributed widely.